The primary aim of this research is to assess the cost-effectiveness of telehealth interventions for patients with Chronic Heart Failure (CHF), in comparison to Usual Care (UC). Our hypothesis is that telemonitoring is cost-effective in comparison to usual care, as demonstrated in previous studies.
The secondary aim of this research is to assess care coordination in the currently predominant business model of CHF telemonitoring (i.e. B2B), and to assess care coordination in a new business model (i.e. B2C). Our hypothesis is that B2C telemonitoring of CHF patients is economically viable and profitable.

In order to fulfill the primary and secondary research aim, a combined main research question has been formulated:
What is the cost-effectiveness of B2B telemonitoring of patients with CHF in comparison to usual care, and is there a more economically viable way to provide care coordination in telemonitoring CHF patients via a B2C model?